CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-06 | DOWNEY BRUCE Director | Conversion · Series A Preferred Stock | −2,000,000 | 0 | ||
| 2020-10-06 | DOWNEY BRUCE Director | Conversion · Series B Preferred Stock | −2,128,571 | 0 | ||
| 2020-10-06 | Salter Malcolm Director | Conversion | +11,856 | 11,856 | ||
| 2020-10-06 | Salter Malcolm Director | Conversion | +2,823 | 14,679 | ||
| 2020-10-06 | Salter Malcolm Director | Purchase | +1,315 | $19.00 | $25K | 15,994 |
| 2020-10-06 | Salter Malcolm Director | Conversion · Series A Preferred Stock | −100,000 | 0 | ||
| 2020-10-06 | Salter Malcolm Director | Conversion · Series B Preferred Stock | −23,809 | 0 | ||
| 2020-10-06 | COHEN ALAIN J Director | Conversion | +237,149 | 237,149 | ||
| 2020-10-06 | COHEN ALAIN J Director | Conversion | +1,482,183 | 1,719,332 | ||
| 2020-10-06 | COHEN ALAIN J Director | Conversion | +2,484,425 | 2,484,425 | ||
| 2020-10-06 | COHEN ALAIN J Director | Conversion · Series Seed Preferred Stock | −2,000,000 | 0 | ||
| 2020-10-06 | COHEN ALAIN J Director | Conversion · Series A Preferred Stock | −12,500,000 | 0 | ||
| 2020-10-06 | COHEN ALAIN J Director | Conversion · Series B Preferred Stock | −20,952,403 | 0 | ||
| 2020-10-06 | Prokupets Elena Director | Conversion | +118,574 | 118,574 | ||
| 2020-10-06 | Prokupets Elena Director | Conversion | +592,873 | 592,873 | ||
| 2020-10-06 | Prokupets Elena Director | Conversion · Series A Preferred Stock | −1,000,000 | 0 | ||
| 2020-10-06 | Prokupets Elena Director | Conversion · Series A Preferred Stock | −5,000,000 | 0 | ||
| 2020-10-01 | Salter Malcolm Director | Grant or award · Stock Option (Right to Buy) | +17,786 | 17,786 | ||
| 2020-10-01 | Hirsch Andrew See Remarks | Grant or award · Stock Option (Right to Buy) | +1,691,672 | 1,691,672 | ||
| 2020-10-01 | COHEN MARC A Director | Grant or award · Stock Option (Right to Buy) | +725,002 | 725,002 |
Page 26 of 27 · 525 trades